Askgene Pharma Inc.

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Aijun Wang

Jian-Feng Lu

Yuefeng Lu

Kurt Shanebeck

Chen Yao

Donggou He

Lan Yang

Lu Li

Fang Xia

The present specification discloses erythropoietin receptor agonists, compositions and medicaments comprising such erythropoietin receptor agonists, methods and uses for such erythropoietin receptor agonists and compositions and medicaments, and methods and uses for erythropoietin receptor agonists and compositions and medicaments for treating an anemia.

Feline erythropoietin receptor agonists

The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.

PD-L1 specific monoclonal antibodies for disease treatment and diagnosis

Growing community of inventors

Camarillo, CA, United States of America

Aijun Wang